is diarrhea a symptom of glp 1 poop smell Your guide to GLP-1 side effects Why Semaglutide Causes Diarrhea: Understanding – GLP-1 side effects are common—You

Leading players Novo Nordisk, Eli Lilly, Boehringer Ingelheim, AstraZeneca, and Sanofi remain at the forefront of this transformation

In 2025, the company delivered a solid +8.56% YoY revenue growth, driven by its immunology portfolio: Skyrizi ($17.56B) continues to surge with strong uptake across psoriasis and IBD, Rinvoq ($8.3B) is expanding rapidly across multiple inflammatory conditions, while Humira ($4.54B) continues to decline following loss of exclusivity marking a clear shift toward newer growth assets

Controlled release of liraglutide using thermogelling polymers in treatment of diabetes

Asia-Pacific is expected to grow at the fastest CAGR during 2025-2034

Exenatide-modified deferoxamine-based nanoparticles ameliorates neurological deficits in Parkinsons disease mice

The firm is selling a controlling stake in its Opella consumer health firm to focus on its science-driven pharma business, and CEO Paul Hudson is bullish about making Sanofi the worlds leading immunology company both through internal development and through dealmaking